CVE:NINE - Delta 9 Cannabis Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
C$1.47 +0.01 (+0.68 %)
(As of 02/22/2019 08:00 AM ET)
Previous CloseC$1.46
Today's RangeC$1.43 - C$1.48
52-Week RangeC$0.95 - C$2.68
Volume69,749 shs
Average Volume116,190 shs
Market CapitalizationC$125.75 million
P/E Ratio-9.36
Dividend YieldN/A
BetaN/A
Delta 9 Cannabis Inc. engages in the production and sale of medical cannabis products. Its products include strains, clones, and LP starting materials. The company also operates a medical clinic that provides physician consultation services to patients seeking a medical recommendation. In addition, the company offers integra boost for preserving the smell of the flowers. Delta 9 Cannabis Inc. is based in Vancouver, Canada.

Receive NINE News and Ratings via Email

Sign-up to receive the latest news and ratings for NINE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$2.60 million
Cash FlowC$0.27 per share
Book ValueC$0.43 per share

Profitability

Miscellaneous

Employees79
Market CapC$125.75 million
Next Earnings DateN/A
OptionableOptionable

Delta 9 Cannabis (CVE:NINE) Frequently Asked Questions

What is Delta 9 Cannabis' stock symbol?

Delta 9 Cannabis trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NINE."

Has Delta 9 Cannabis been receiving favorable news coverage?

News coverage about NINE stock has been trending very negative on Friday, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Delta 9 Cannabis earned a news sentiment score of -3.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the company's share price in the next several days.

Who are some of Delta 9 Cannabis' key competitors?

What other stocks do shareholders of Delta 9 Cannabis own?

Who are Delta 9 Cannabis' key executives?

Delta 9 Cannabis' management team includes the folowing people:
  • Mr. John William Arbuthnot IV, CEO & Director (Age 29)
  • Mr. John William Arbuthnot III, Chairman & Pres (Age 65)
  • Mr. Jim Lawson, Interim CFO & Controller
  • Mr. Gary Symons, Director of Communications

How do I buy shares of Delta 9 Cannabis?

Shares of NINE and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Delta 9 Cannabis' stock price today?

One share of NINE stock can currently be purchased for approximately C$1.47.

How big of a company is Delta 9 Cannabis?

Delta 9 Cannabis has a market capitalization of C$125.75 million and generates C$2.60 million in revenue each year. Delta 9 Cannabis employs 79 workers across the globe.

What is Delta 9 Cannabis' official website?

The official website for Delta 9 Cannabis is http://www.delta9.ca.


MarketBeat Community Rating for Delta 9 Cannabis (CVE NINE)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  25 (Vote Outperform)
Underperform Votes:  18 (Vote Underperform)
Total Votes:  43
MarketBeat's community ratings are surveys of what our community members think about Delta 9 Cannabis and other stocks. Vote "Outperform" if you believe NINE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NINE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/22/2019 by MarketBeat.com Staff

Featured Article: Retained Earnings

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel